OR
AXDX

Olympiad Research’s Accelerate Diagnostics AXDX Stock Holding History

Olympiad Research’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,173
Closed -$113K – 339
2021
Q4 		$113K Buy
2,173
+1,035
+91% +$57.6K 0.04% 243
2021
Q3 		$66K Buy
+1,138
New +$74.2K 0.02% 250
2020
Q2 		– Sell
-1,928
Closed -$161K – 295
2020
Q1 		$161K Buy
+1,928
New +$271K 0.16% 217

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Olympiad Research's AXDX Position: Q1 2022 in Review

Olympiad Research sold out of Accelerate Diagnostics (AXDX) in Q1 2022, closing a stake of 2,173 shares — an estimated $113K sold.

Olympiad Research first reported a position in AXDX in Q1 2020 and held it in 3 quarters. The position peaked at $161K in Q1 2020. 106 funds tracked by Wall St. Rank hold AXDX as of Q1 2022.

  • Olympiad Research reported no remaining Accelerate Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Olympiad Research sold 2,173 Accelerate Diagnostics shares in Q1 2022, an estimated $113K.
  • Olympiad Research first reported a position in Accelerate Diagnostics in Q1 2020 and held it in 3 quarters.
  • Olympiad Research's Accelerate Diagnostics position peaked at $161K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2022.

Based on Olympiad Research's 13F filing for Q1 2022, filed 10 May 2022.